Slow-release sodium fluoride in osteoporosis

Journal of Bone and Mineral Research

Volumn 11, Issue 5, 1996, Pages 561-564

  Pak, Charles Y C ^a   Zerwekh, Joseph E ^a   Antich, Peter P ^a   Bell, Norman H ^b   Singer, Frederick R ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c SAINT JOHN'S HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CITRATE CALCIUM; ESTROGEN; FLUORIDE SODIUM;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OCCULT BLOOD; ORAL DRUG ADMINISTRATION; OSSIFICATION; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SPINE FRACTURE; SUSTAINED RELEASE PREPARATION;

EID: 0029863115     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650110502     Document Type: Review

References (16)

1. Pak CYC, Sakhaee K, Adams-Huet B, Piziak V, Peterson RD, Poindexter J 1995 Treatment of postmenopausal osteoporosis with slow-release sodium fluoride: Final update of a randomized controlled trial. Ann Intern Med 123:401-408,
2. Briancon D, Meunier PJ 1981 Treatment of osteoporosis with fluoride calcium and vitamin D. Ortho Clin North Am 12:629-648.
3. Pak CYC, Zerwekh JE, Antich PP 1995 Anabolic effects of fluoride. Trends Endocrinol Metab 6:229-234.
4. Pak CYC, Sakhaee K, Bell N, Licata A, Johnston C, Rubin C, Bonnick S, Piziak V, Graham H, Ballard J, Berger R, Fears W, Adams-Huet B 1996 Controlled comparison of a non-randomized trial with slow release sodium fluoride with a randomized controlled trial in postmenopausal osteoporosis. J Bone Miner Res 11:160-168.
5. Zerwekh JE, Antich PP, Sakhaee K, Prior J, Gonzales J, Gottschalk F, Pak CYC 1992 Lack of deleterious effect of slow-release sodium fluoride treatment on cortical bone histology and quality in osteoporosis patients. Bone Miner 18:65-76.
6. Zerwekh JE, Hagler H, Sakhaee K, Gottschalk F, Pak CYC 1994 Effect of slow-release sodium fluoride on cancellous bone histology and connectivity in osteoporosis: Trabecular strut analysis. Bone 15:691-699.
7. Antich PP, Anderson JA, Ashman RB, Dowdey JE, Gonzales J, Murry RC, Zerwekh JE, Pak CYC 1991 Measurement of mechanical properties of bone material in vitro by ultrasound reflection: Methodology and comparison with ultrasound transmission. J Bone Miner Res 6:417-426.
8. Pak CYC, Sakhaee K, Antich P, Zerwekh J, Peterson R, Piziak V, Gonzales J, Hatab M, Poindexter J 1993 Update on the treatment of osteoporosis with intermittent slow-release sodium fluoride and continuous calcium citrate. Fourth International Symposium on Osteoporosis. Hong Kong, March 27-April 1, 1993, pp. 122-124.
9. Antich PP, Pak CYC, Gonzales J, Anderson J, Sakhaee K, Rubin C 1993 Measurement of intrinsic bone strength in vivo by reflection ultrasound: Correction of impaired quality with slow-release sodium fluoride and calcium citrate. J Bone Miner Res 8:301-311.
10. Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, et al. 1995 Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. New Engl J Med 333:1437-1443.
11. Riggs BL, Hodgson SF, O'Fallon MW, Chao EY, Wahner HW, Muhs JM, Cedel SL, and Melton JL, III 1990 Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. New Engl J Med 322:802-809.
12. Melton LJ III, Istrup DM, Riggs BL 1982 Fifty-year trend in hip fracture incidence. Clin Orthop 162:144-149.
13. Riggs LB, Baylink DJ, Kleerekoper M, Lane JM, Melton JL III, Meunier PJ, Incidence of hip fractures in osteoporotic women treated with sodium fluoride 1987 Bone Miner Res 2:123-126.
14. Lundy MW, Stauffer M, Wergedal JE, Baylink DJ, Featherstone JDB, Hodgson SF, Riggs BL 1995 Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects. Osteoporosis Int 5:115-129.
15. Mamelle N, Dusao R, Prost A, Martin JL, Meunier PJ, Guillaume M, Gaucher A, Zeigler G 1988 Risk benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet ii:361-365.
16. Mamelle N, Meunier PJ, Netter P 1990 Fluoride and vertebral fractures. Lancet 336:243.